In response to a lawsuit, the FDA has said that it will reevaluate its previous decision to remove tirzepatide from its ...
On October 7, a compounding trade group filed a lawsuit challenging the agency's action, saying there was still a shortage of the wildly popular drug.
,A weight-loss drug more effective than Ozempic and Wegovy has recently been approved in Australia. The drug, tirzepatide, is ...
Mounjaro and Zepbound are now out of shortage. This should be good news—but because so many patients are taking compounded ...
The FDA is weighing a decision that could stop compounding pharmacies from legally making cheaper versions of Mounjaro and ...
Tirzepatide, a cutting-edge medication initially approved for the treatment of type 2 diabetes, has shown remarkable potential in facilitating significant weight loss. This dual GIP and GLP-1 receptor ...
Eli Lilly's valuation could look much more modest in the future, as its earnings should continue to grow at a high rate.
A group of health professionals have called for a review of obesity management services in light of increased public demand ...